Education
About Us
Working with TipRanks
Follow Us
Achilles Therapeutics (ACHL)
NASDAQ:ACHL
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -4.73M | $ -3.69M | $ -3.29M | $ -778.00K | $ -303.25K |
| Operating Income | $ -75.25M | $ -78.38M | $ -64.19M | $ -33.73M | $ -13.78M |
| EBITDA | $ -70.44M | $ -78.38M | $ -57.77M | $ -32.95M | $ -13.47M |
| Net Income | $ -69.67M | $ -71.18M | $ -61.10M | $ -33.20M | $ -13.99M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 131.54M | $ 173.34M | $ 266.32M | $ 177.85M | $ 97.59M |
| Total Assets | $ 161.46M | $ 220.36M | $ 317.11M | $ 218.92M | $ 105.20M |
| Total Debt | $ 4.62M | $ 8.58M | $ 12.26M | $ 15.98M | $ 487.00K |
| Net Debt | $ -126.92M | $ -164.76M | $ -254.06M | $ -161.87M | $ -97.11M |
| Total Liabilities | $ 19.09M | $ 23.31M | $ 27.58M | $ 29.55M | $ 3.86M |
| Stockholders' Equity | $ 142.37M | $ 197.04M | $ 289.53M | $ 189.37M | $ 101.35M |
| Cash Flow | |||||
| Free Cash Flow | $ -49.55M | $ -67.05M | $ -66.92M | $ -37.10M | $ -15.08M |
| Operating Cash Flow | $ -48.45M | $ -59.53M | $ -59.28M | $ -25.25M | $ -14.14M |
| Investing Cash Flow | $ -1.10M | $ -7.51M | $ -7.63M | $ -11.85M | $ -942.00K |
| Financing Cash Flow | $ 9.00K | $ 1.00K | $ 160.75K | $ 113.70M | $ 93.62M |